Clinical Trial Update: Freder1k-Study - Testing Infants for Type 1 Diabetes Risk

View source ↗

Summary

The Freder1k-Study is currently recruiting to identify infants at risk for Type 1 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Helmholtz Zentrum München | Conditions: Identification of Infants at Risk for Type 1 Diabetes | Status: RECRUITING